SLShihua Luo

Shihua Luo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shihua Luo has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Chao Liu

    Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China

    1 shared publication
  • Chunfang Wang

    Affiliated Hospital of Youjiang Medical University for Nationalities

    1 shared publication
  • Dan Liu

    Faculty of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, PR China; Faculty of Chemical Engineering and Light Industry, Guangdong Provincial Key Laboratory of Plant Resources Biorefinery, Guangdong University of Technology, Guangzhou 510006, PR China

    1 shared publication
  • Fei Lin

    The First Affiliated Hospital of Xinxiang Medical College, Xinxiang, Henan, China

    1 shared publication
  • Fu Chai

    Center for Medical Laboratory Science, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise 533000, Guangxi, China; Graduate School of Youjiang Medical University for Nationalities, Baise 533000, Guangxi, China

    1 shared publication
  • Guang Chen

    Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong

    1 shared publication

Latest Publications

  • Effect of M0 macrophage-derived exosome miR-181d-5p targeting BCL-2 to regulate NLRP3/caspase-1/GSDMD pathway on human renal mesangial cells pyroptosis

    by Fu Chai, Xu Chang, Yingliang Lin, Xiaoxia Pang, Shihua Luo, Huatuo Huang, Linxiu Qin, Yan Lan, Yonglong Zeng, Chunfang Wang


  • Open Access

    Clinical characteristics and outcomes of 2019 novel coronavirus disease patients presenting with initial gastrointestinal symptoms in Wuhan, China: A retrospective cohort study

    by Shihua Luo, Zhiqing Deng, Xiaochun Zhang, Zhenyu Pan, Haibo Xu

    Background and Aim: Patients with 2019 novel coronavirus disease (COVID‐19) could present with gastrointestinal symptoms without fever or respiratory manifestations, which could be overlooked by health‐care providers. We aimed to evaluate the clinical characteristics of COVID‐19 in patients presenting with initial gastrointestinal symptoms.Methods: We evaluated all confirmed cases of COVID‐19 in Zhongnan Hospital of Wuhan University between January 10 and February 29, 2020. We divided these patients into two groups: patients with initial gastrointestinal symptoms (group A, n = 183) and patients with respiratory syndrome and/or fever (group B, n = 1228). The clinical characteristics, radiological features, and laboratory data were assessed.Results: The clinical procedures of both groups underwent 1–2 weeks rising period and were downward trend at 3 weeks; less than 5% of patients progressed to critical illness. In both groups, mean leukocyte count (P = 0.354) and lymphocyte count (P = 0.386) were below normal, and C‐reactive protein level was elevated (P = 0.412). There was mild liver function injury (aspartate aminotransferase, 65.8 ± 12.7 vs 67.4 ± 9.3 U/L, P = 0.246; alanine aminotransferase, 66.4 ± 13.2 vs 69.6 ± 12.7 U/L, P = 0.352), and normal renal function was intact (blood urea nitrogen 6.4 ± 2.5 vs 5.6 ± 2.8 mmol/L P = 0.358; creatinine 85.7 ± 37.2, 91.2 ± 32.6 μmol/L, P = 0.297). After a series of treatment, 176 and 1169 were stable and alive in groups A and B, respectively. The survival rate did not differ significantly between the groups (P = 0.313).Conclusion: COVID‐19 patients presented with initial gastrointestinal symptoms had similar clinical characteristics and outcomes, when compared with patients with fever and respiratory symptoms.


  • Open Access

    Direct Intrahepatic Portocaval Shunt for Sinusoidal Obstruction Syndrome Associated with Hepatotoxicity of Pyrrolizidine Alkaloids

    by Shihua Luo, Jianguo Chu, He Huang, Kechun Yao

    We retrospectively identified 89 consecutive patients from January 2004 to January 2012 to investigate efficacy of direct intrahepatic portocaval shunt (DIPS) combined with inferior vena cava (IVC) stenting for sinusoidal obstruction syndrome (SOS) associated with hepatotoxicity of pyrrolizidine alkaloids. Indications for treatment were variceal hemorrhage and/or refractory ascites. Patients were treated with DIPS plus IVC stenting (group A, n=68) or DIPS alone (group B, n=21). A technical success rate of 100% was obtained in all 89 patients, and there were no early procedure-related adverse events or 30-day mortality. Mean portosystemic gradient decreased in both groups. Changes in aspartate and alanine aminotransferases and total bilirubin did not differ between the groups. Ascites disappeared in group A but was not obvious in group B until IVC stenting. During follow-up, recurrent bleeding and ascites and incidence of hepatic encephalopathy did not differ between the groups. The 1-, 3-, and 5-year survival rate was 98, 89.59, and 80%, respectively. Satisfactory clinical results were obtained for combined DIPS and IVC stenting for SOS associated with pyrrolizidine-alkaloid-related decompensated cirrhosis.


  • Open Access

    Observational Study of the Association between TCM Zheng and Types of Coronary Artery Stenosis: Protocol of a Multicenter Case Series Study

    by Chao Liu, Guang Chen, Dan Liu, Shaoping Nie, Xiao Wang, Xinsheng Huang, Haitao Li, Yi Li, Shihua Luo, Guoan Zhao, et al.

    Background. Coronary artery stenosis is the major pathological change of coronary heart disease (CHD). Within the framework of traditional Chinese medicine (TCM) theory, some kinds of TCM Zheng could exist in patients with CHD; accordingly, TCM practitioners could provide appropriate TCM therapy. However, little is known about the association between TCM Zheng and types of coronary artery stenosis. Such knowledge could help improve the accuracy and effectiveness of efforts to combine CHD treatment with TCM therapy. Therefore, the aim of this study is to determine the association between TCM Zheng and types of coronary artery stenosis. Methods and Design. This is a multicenter, large sample, case series study in 4 tertiary A hospitals from 3 provinces in China. A total of 3,000 eligible patients diagnosed with atherosclerosis or CHD and selected to undergo coronary angiography (CAG) will be enrolled in this study. We will use electronic case report forms (eCRF) to collect information, including baseline characteristics, TCM symptoms, CAG results, and GRACE scores according to standard operating procedures (SOP). Data will be analyzed by SPSS 20.0. Ethics. This study is approved by the Ethics Committee of Guang’anmen Hospital of the China Academy of Chinese Medical Sciences (no. 2017‐058‐KY‐01) and is registered with chictr.org (registration number ChiCTR-ROC-17013221).


  • Open Access

    Analysis on Influence of Stock of Education Capital and Fixed Assets on GDP Based on Three Types of Regression Model

    by Zu-Chang Zhong, Shi-Hua Luo, Wen-Cheng Wang, Xue-Ying Chen, Yi-Lin Wei, Wei-Rong Mo

    The investment of education capital and fixed assets play an important role in the economic growth of one country, while traditional regression analysis may underestimate or overestimate the contribution of the investment of education capital and fixed assets on economic growth. In this paper,...